MINNEAPOLIS–(BUSINESS WIRE)–The Board of Directors of Graco Inc. (NYSE:GGG) has declared a regular quarterly dividend of 29.5 cents ($0.295) per common share, payable on November 4, 2026, to shareholders of record at the close of business on October 19, 2026. The Company has approximately 160.4 million shares outstanding.ABOUT GRACOGraco Inc. supplies technology and expertise for the management of fluids and coatings in both industrial and commercial applications. It designs, manufactures and
Month: September 2026
PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today announced today that they will participate in the following upcoming investor conferences: The 2026 Jefferies Healthcare Services and Technology Conference, being held in Nashville, on Monday, September 14, 2026, including a
DENVER–(BUSINESS WIRE)–Tungsten Automation, a global leader in document and workflow automation, today announced it has been named a Leader in the 2026 Gartner Magic Quadrant for Intelligent Document Processing (IDP). Gartner has now named the company a Leader in both IDP Magic Quadrant reports it has published to date. Gartner evaluates IDP vendors on completeness of vision and ability to execute. Tungsten Automation believes its position reflects two years of steady delivery for customers:
NUEVA YORK Y PARÍS–(BUSINESS WIRE)–Owkin, empresa de inteligencia artificial agentiva pionera en el desarrollo del primer científico de IA automatizado con el objetivo de revolucionar el descubrimiento y el desarrollo de fármacos, acaba de anunciar un acuerdo con Servier, grupo farmacéutico internacional independiente gestionado por una fundación, para conceder una licencia de K Pro, el científico de IA de Owkin, además de datos multimodales de pacientes, para impulsar la investigación oncoló
NEW YORK e PARIGI–(BUSINESS WIRE)–Owkin, azienda di AI agentica che ha creato il primo scienziato AI automatizzato per rivoluzionare la scoperta e lo sviluppo in ambito farmacologico, oggi ha annunciato la sigla di un accordo con Servier, gruppo farmaceutico indipendente e internazionale diretto da una fondazione, relativo alla concessione in licenza di K Pro, lo scienziato AI di Owkin, oltre a dati multimodali sui pazienti, per promuovere la ricerca oncologica da parte dell’azienda. In base
NEW YORK & PARIS–(BUSINESS WIRE)–Owkin, das Unternehmen für agentenbasierte KI, das Pionierarbeit bei der Entwicklung des ersten automatisierten KI-Wissenschaftlers leistet, um die Wirkstoffforschung und -entwicklung zu revolutionieren, gab heute eine Vereinbarung mit Servier bekannt, einem unabhängigen internationalen Pharmakonzern, der von einer Stiftung geleitet wird. Im Rahmen dieser Vereinbarung wird K Pro, der KI-Wissenschaftler von Owkin, zusammen mit multimodalen Patientendaten lizenz
WASHINGTON–(BUSINESS WIRE)– #CleaningIsCaring–As the American Cleaning Institute (ACI) celebrates the centennial anniversary of its founding in 1926, U.S. Rep. Rick Allen (R-GA) introduced a congressional resolution honoring 100 years of ACI and recognizing the essential role cleaning and the U.S. cleaning products industry play in protecting health, supporting American jobs and manufacturing, and helping communities thrive.Rep. Allen is a leading member of the House Energy & Commerce Committee and has been
NORTH LIBERTY, Iowa, Sept. 11, 2026 (GLOBE NEWSWIRE) — Heartland Express, Inc. (Nasdaq: HTLD) announced that Chris Strain, Chief Financial Officer, will participate at the Morgan Stanley 14th Annual Laguna Conference on Tuesday, September 15, 2026.
Heartland Express is an irregular route truckload carrier based in North Liberty, Iowa serving customers with shipping lanes throughout the United States and Mexico. Heartland focuses primarily on regional freight, offering shippers industry leading on-time service so they can achieve their strategic goals for their customers. More information about Heartland Express can be found on the company website at www.heartlandexpress.com.
Information presented at the conference may contain forward-looking statements made by Heartland. Forward-looking statements are based upon the current beliefs and expectations of Heartland’s management and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, which could cause future events and actual results to differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. Accordingly, actual results may differ from those set forth in the forward-looking statements. Readers should review and consider the factors that may affect future results and other disclosures by Heartland in its press releases, stockholder reports, Annual Report on Form 10-K, and other filings with the Securities and Exchange Commission. Heartland disclaims any obligation to update or revise any forward-looking statements to reflect actual results or changes in the factors affecting the forward-looking information.
Contact:
Heartland Express, Inc.
Mike Gerdin, Chief Executive Officer
Chris Strain, Chief Financial Officer
319-645-7060
Transparency notification by
BNP Paribas Asset Management Holding
and BNP Paribas Cardif
In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by BNP Paribas Asset Management Holding and BNP Paribas Cardif that they had crossed above the legal threshold of 3% of direct voting rights on 4 September 2026.
The total holding of direct voting rights and equivalent financial instruments of BNP Paribas Asset Management Holding and BNP Paribas Cardif stood at 3.06% on 4 September 2026.
Summary of the move:
| Date on which the threshold was crossed | Date of notification | Direct voting rights after the transaction | Equivalent financial instruments after the transaction | Total |
| 4 September 2026 | 8 September 2026 | 3.06% | 0.00% | 3.06% |
Notification from BNP Paribas Asset Management Holding and BNP Paribas Cardif:
The notification contains the following information:
- Date of notification: 8 September 2026
- Date on which the threshold was crossed: 4 September 2026
- Threshold of direct voting rights crossed upwards: 3%
- Notification by: BNP Paribas Asset Management Holding and BNP Paribas Cardif
- Denominator: 246,400,000
- Reason for notification: Acquisition or disposal of voting securities or voting rights
Transparency notifications and the full chain of controlled undertakings through which the holding is effectively held are available on the Transparency Declaration section of Umicore’s website.
About Umicore
Umicore is a global advanced materials and recycling Group. Leveraging decades of expertise in materials science, metallurgy, chemistry, and metals management, Umicore transforms precious and critical metals into functional technologies that enable everyday applications. Its unique circular business model ensures that these critical elements are continuously refined and recycled, to be reintegrated in new applications.
Umicore’s four Business Groups – Catalysis, Recycling, Specialty Materials and Battery Materials Solutions – offer materials and solutions addressing resource scarcity and the growing need for functional materials for clean technologies, clean mobility and a connected world. Through tailored and cutting-edge products and processes they drive innovation and sustainability.
Umicore generates the majority of its revenues from, and focuses most of its R&D efforts on, clean mobility and recycling. Its overriding goal of sustainable value creation is rooted in developing, producing and recycling materials for a better life.
Umicore’s industrial, commercial and R&D activities, with more than 11,000 employees, are located across the world to best serve its global customer base. Group revenues (excluding metal) reached € 1.9 billion (turnover of € 13.9 billion) in the first half of 2026.
For more information
| Caroline Kerremans | +32 2 227 72 21 | caroline.kerremans@umicore.com |
| Bart Heylen | +32 2 227 73 09 | bart.heylen@umicore.com |
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)
Sanofi
a French société anonyme with a registered share capital of €2,415,546,786
Registered office : 46, avenue de la Grande Armée – 75017 Paris – France
Registered at the Paris Commercial and Companies Registry under number 395 030 844
| Date |
Total number of
|
Number of real voting rights (excluding treasury shares) |
Theoretical number of voting rights (including treasury shares)* |
| August 31, 2026 |
1,207,773,393 |
1,336,151,933 |
1,343,318,995 |
* Pursuant to Article 223-11 of the Règlement général de l’Autorité des Marchés Financiers.
This information is also available on the internet website of sanofi:
https://www.sanofi.com/en/investors/sanofi-share-and-adrs/shares-structure-vote
| Investor Relations Department e-mail: investor.relations@sanofi.com
|
Attachment
